All In Biotech

Investigational drug · Phase 3

barzolvolimab

Also called: CDX-0159

Not approved by FDA. In 7 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

7

6 still active

All registered trials

10

Any phase or sponsor naming "barzolvolimab"

First trial start

2023

Jun 1, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "barzolvolimab", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Chronic Spontaneous Urticaria
  • Chronic Inducible Urticaria
  • Cold Urticaria
  • Cold-Induced Urticaria
  • Symptomatic Dermographism
  • Prurigo Nodularis
  • Atopic Dermatitis
  • Eosinophilic Esophagitis

Approved drugs for the same conditions: Atopic dermatitis (eczema) · Chronic hives (urticaria) · Eosinophilic esophagitis · Immunology and inflammation · Gastroenterology and liver · Dermatology

Largest trials

Live from ClinicalTrials.gov: studies naming "barzolvolimab" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 33 on PubMed

Also in development for Chronic Spontaneous Urticaria

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • JYB1904RPT904, ozureprubartPhase 35 trials

    Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • BLU-808Phase 22 trials

    Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis

  • BBT001Phase 21 trial

    Bambusa Therapeutics · Chronic Spontaneous Urticaria

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.